{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:13:38Z","timestamp":1788873218653,"version":"build-2803163510"},"reference-count":228,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":250,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neurodegenerative diseases, including Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD), are becoming increasingly prevalent in today\u2019s aging population and with significant cost to society. While these diseases were traditionally defined by distinct protein aggregates, namely, tau tangles and amyloid-\u03b2 (A\u03b2) plaques in AD and \u03b1-synuclein (\u03b1-syn) inclusions in PD, substantial evidence reveals frequent mixed pathologies, with tau, \u03b1-syn, and A\u03b2 aggregates coexisting in patients. This copathology complicates understanding disease mechanisms, classification, and progression, highlighting the need to examine mixed pathologies in neurodegenerative diseases to develop disease-modifying therapies. The presence of mixed proteinopathies suggests shared or converging pathological mechanisms, including synergistic aggregation, enhanced seeding capabilities, and shared protein\u2013protein interactions. Understanding these molecular mechanisms is essential for identifying disease modifiers and refining experimental models. This review explores the pathogenic mechanisms of \u03b1-syn and tau individually, followed by exploration of their molecular interactions and potential mechanisms of coaggregation and exacerbation of pathology. By recognizing the intersection of these pathologies, further research can refine disease classifications for neurodegenerative diseases.<\/jats:p>","DOI":"10.1007\/s12035-026-06163-6","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:48:31Z","timestamp":1788828511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["When Pathologies Collide: The Intersection of Tau and Alpha-Synuclein in Neurodegenerative Diseases"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2566-8428","authenticated-orcid":false,"given":"Jenna N.","family":"Hunt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3532-8669","authenticated-orcid":false,"given":"Sandhya","family":"Kortagere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"6163_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.937486","volume":"14","author":"X Li","year":"2022","unstructured":"Li X, Feng X, Sun X et al (2022) Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132019. Front Aging Neurosci 14. https:\/\/doi.org\/10.3389\/fnagi.2022.937486","journal-title":"Front Aging Neurosci"},{"key":"6163_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Elbaz A, Nichols E et al (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939\u2013953. https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"6163_CR3","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the Parkinson pandemic. J Park Dis 8:S3\u2013S8. https:\/\/doi.org\/10.3233\/JPD-181474","journal-title":"J Park Dis"},{"key":"6163_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccb.2025.100377","volume":"8","author":"Y Li","year":"2025","unstructured":"Li Y, J\u00f6nsson L (2025) The health and economic burden of brain disorders: consequences for investment in diagnosis, treatment, prevention and R&D. Cereb Circ - Cogn Behav 8. https:\/\/doi.org\/10.1016\/j.cccb.2025.100377","journal-title":"Cereb Circ - Cogn Behav"},{"key":"6163_CR5","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly BS, Lang AE (2014) Pharmacological treatment of Parkinson disease: a review. JAMA 311:1670. https:\/\/doi.org\/10.1001\/jama.2014.3654","journal-title":"JAMA"},{"key":"6163_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH Van Dyck","year":"2023","unstructured":"Van Dyck CH, Swanson CJ, Aisen P et al (2023) Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 388:9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"N Engl J Med"},{"key":"6163_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.42.3.631","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease. Neurology 42:631\u2013631. https:\/\/doi.org\/10.1212\/WNL.42.3.631","journal-title":"Neurology"},{"key":"6163_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885\u2013890. https:\/\/doi.org\/10.1016\/S0006-291X(84)80190-4","journal-title":"Biochem Biophys Res Commun"},{"key":"6163_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0006-8993(99)01848-X","volume":"843","author":"K Arima","year":"1999","unstructured":"Arima K, Hirai S, Sunohara N et al (1999) Cellular co-localization of phosphorylated tau- and NACP\/\u03b1-synuclein-epitopes in Lewy bodies in sporadic Parkinson\u2019s disease and in dementia with Lewy bodies. Brain Res 843:53\u201361. https:\/\/doi.org\/10.1016\/S0006-8993(99)01848-X","journal-title":"Brain Res"},{"key":"6163_CR10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM-Y et al (1997) \u03b1-Synuclein in Lewy bodies. Nature 388:839\u2013840. https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"key":"6163_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","volume":"134","author":"TL Spires-Jones","year":"2017","unstructured":"Spires-Jones TL, Attems J, Thal DR (2017) Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol (Berl) 134:187\u2013205. https:\/\/doi.org\/10.1007\/s00401-017-1709-7","journal-title":"Acta Neuropathol (Berl)"},{"key":"6163_CR12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","volume":"14","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Lee VM-Y, Trojanowski JQ (2013) Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies. Nat Rev Neurosci 14:626\u2013636. https:\/\/doi.org\/10.1038\/nrn3549","journal-title":"Nat Rev Neurosci"},{"key":"6163_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/jnen\/62.4.389","volume":"62","author":"T Ishizawa","year":"2003","unstructured":"Ishizawa T, Mattila P, Davies P et al (2003) Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. J Neuropathol Exp Neurol 62:389\u2013397. https:\/\/doi.org\/10.1093\/jnen\/62.4.389","journal-title":"J Neuropathol Exp Neurol"},{"key":"6163_CR14","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/alz.12291","volume":"17","author":"KE McAleese","year":"2021","unstructured":"McAleese KE, Colloby SJ, Thomas AJ et al (2021) Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia. Alzheimers Dement J Alzheimers Assoc 17:1121\u20131133. https:\/\/doi.org\/10.1002\/alz.12291","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"6163_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin DJ, Grossman M, Weintraub D et al (2017) Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16:55\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(16)30291-5","journal-title":"Lancet Neurol"},{"key":"6163_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0006-8993(00)03082-1","volume":"888","author":"Y Arai","year":"2001","unstructured":"Arai Y, Yamazaki M, Mori O et al (2001) \u03b1-Synuclein-positive structures in cases with sporadic Alzheimer\u2019s disease: morphology and its relationship to tau aggregation. Brain Res 888:287\u2013296. https:\/\/doi.org\/10.1016\/S0006-8993(00)03082-1","journal-title":"Brain Res"},{"key":"6163_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1212\/01.wnl.0000138440.39918.0c","volume":"63","author":"N Scarmeas","year":"2004","unstructured":"Scarmeas N, Hadjigeorgiou GM, Papadimitriou A et al (2004) Motor signs during the course of Alzheimer disease. Neurology 63:975\u2013982. https:\/\/doi.org\/10.1212\/01.wnl.0000138440.39918.0c","journal-title":"Neurology"},{"key":"6163_CR18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4172\/2161-0460.1000444","volume":"8","author":"DJ Irwin","year":"2018","unstructured":"Irwin DJ, Hurtig HI (2018) The contribution of tau, amyloid-beta and alpha-synuclein pathology to dementia in Lewy body disorders. J Alzheimers Dis Park 8:444. https:\/\/doi.org\/10.4172\/2161-0460.1000444","journal-title":"J Alzheimers Dis Park"},{"key":"6163_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2022.102270","volume":"214","author":"U Sengupta","year":"2022","unstructured":"Sengupta U, Kayed R (2022) Amyloid \u03b2, tau, and \u03b1-synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases. Prog Neurobiol 214. https:\/\/doi.org\/10.1016\/j.pneurobio.2022.102270","journal-title":"Prog Neurobiol"},{"key":"6163_CR20","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202409104","volume":"224","author":"V Uytterhoeven","year":"2024","unstructured":"Uytterhoeven V, Verstreken P, Nachman E (2024) Synaptic sabotage: how tau and \u03b1-synuclein undermine synaptic health. J Cell Biol 224. https:\/\/doi.org\/10.1083\/jcb.202409104","journal-title":"J Cell Biol"},{"key":"6163_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.semcdb.2018.05.005","volume":"99","author":"X Yan","year":"2020","unstructured":"Yan X, Uronen R-L, Huttunen HJ (2020) The interaction of \u03b1-synuclein and tau: a molecular conspiracy in neurodegeneration? Semin Cell Dev Biol 99:55\u201364. https:\/\/doi.org\/10.1016\/j.semcdb.2018.05.005","journal-title":"Semin Cell Dev Biol"},{"key":"6163_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1570553","volume":"19","author":"FJ Padilla-God\u00ednez","year":"2025","unstructured":"Padilla-God\u00ednez FJ, V\u00e1zquez-Garc\u00eda ER, Trujillo-Villagr\u00e1n MI et al (2025) \u03b1-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies. Front Neurosci 19. https:\/\/doi.org\/10.3389\/fnins.2025.1570553","journal-title":"Front Neurosci"},{"key":"6163_CR23","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","volume":"8","author":"L Maroteaux","year":"1988","unstructured":"Maroteaux L, Campanelli J, Scheller R (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804\u20132815. https:\/\/doi.org\/10.1523\/JNEUROSCI.08-08-02804.1988","journal-title":"J Neurosci"},{"key":"6163_CR24","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/JPD-150642","volume":"5","author":"J Burr\u00e9","year":"2015","unstructured":"Burr\u00e9 J (2015) The synaptic function of \u03b1-synuclein. J Park Dis 5:699\u2013713. https:\/\/doi.org\/10.3233\/JPD-150642","journal-title":"J Park Dis"},{"key":"6163_CR25","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burr\u00e9","year":"2010","unstructured":"Burr\u00e9 J, Sharma M, Tsetsenis T et al (2010) \u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329:1663\u20131667. https:\/\/doi.org\/10.1126\/science.1195227","journal-title":"Science"},{"key":"6163_CR26","doi-asserted-by":"publisher","first-page":"29542","DOI":"10.1074\/jbc.M115.691592","volume":"290","author":"B Butler","year":"2015","unstructured":"Butler B, Saha K, Rana T et al (2015) Dopamine transporter activity is modulated by \u03b1-synuclein. J Biol Chem 290:29542\u201329554. https:\/\/doi.org\/10.1074\/jbc.M115.691592","journal-title":"J Biol Chem"},{"key":"6163_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich A, Schmitz Y, Fari\u00f1as I et al (2000) Mice lacking \u03b1-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25:239\u2013252. https:\/\/doi.org\/10.1016\/S0896-6273(00)80886-7","journal-title":"Neuron"},{"key":"6163_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214050","volume":"23","author":"R Trivedi","year":"2022","unstructured":"Trivedi R, Nagarajaram HA (2022) Intrinsically disordered proteins: an overview. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms232214050","journal-title":"Int J Mol Sci"},{"key":"6163_CR29","doi-asserted-by":"publisher","first-page":"15345","DOI":"10.1074\/jbc.M111.318949","volume":"287","author":"B Fauvet","year":"2012","unstructured":"Fauvet B, Mbefo MK, Fares M-B et al (2012) \u03b1-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. J Biol Chem 287:15345\u201315364. https:\/\/doi.org\/10.1074\/jbc.M111.318949","journal-title":"J Biol Chem"},{"key":"6163_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels T, Choi JG, Selkoe DJ (2011) \u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477:107\u2013110. https:\/\/doi.org\/10.1038\/nature10324","journal-title":"Nature"},{"key":"6163_CR31","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","volume":"322","author":"HA Lashuel","year":"2002","unstructured":"Lashuel HA, Petre BM, Wall J et al (2002) \u03b1-Synuclein, especially the Parkinson\u2019s disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322:1089\u20131102. https:\/\/doi.org\/10.1016\/S0022-2836(02)00735-0","journal-title":"J Mol Biol"},{"key":"6163_CR32","doi-asserted-by":"publisher","first-page":"6925","DOI":"10.1021\/bi400999d","volume":"52","author":"D Ghosh","year":"2013","unstructured":"Ghosh D, Mondal M, Mohite GM et al (2013) The Parkinson\u2019s disease-associated H50Q mutation accelerates \u03b1-synuclein aggregation in vitro. Biochemistry 52:6925\u20136927. https:\/\/doi.org\/10.1021\/bi400999d","journal-title":"Biochemistry"},{"key":"6163_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep37130","volume":"6","author":"M-R Ma","year":"2016","unstructured":"Ma M-R, Hu Z-W, Zhao Y-F et al (2016) Phosphorylation induces distinct alpha-synuclein strain formation. Sci Rep 6. https:\/\/doi.org\/10.1038\/srep37130","journal-title":"Sci Rep"},{"key":"6163_CR34","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J et al (2012) Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338:949\u2013953. https:\/\/doi.org\/10.1126\/science.1227157","journal-title":"Science"},{"key":"6163_CR35","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner B, Jappelli R, Maji SK et al (2011) In vivo demonstration that \u03b1-synuclein oligomers are toxic. Proc Natl Acad Sci U S A 108:4194\u20134199. https:\/\/doi.org\/10.1073\/pnas.1100976108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6163_CR36","doi-asserted-by":"publisher","first-page":"8083","DOI":"10.1523\/JNEUROSCI.1091-10.2010","volume":"30","author":"DA Scott","year":"2010","unstructured":"Scott DA, Tabarean I, Tang Y et al (2010) A pathologic cascade leading to synaptic dysfunction in \u03b1-synuclein-induced neurodegeneration. J Neurosci 30:8083\u20138095. https:\/\/doi.org\/10.1523\/JNEUROSCI.1091-10.2010","journal-title":"J Neurosci"},{"key":"6163_CR37","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1073\/pnas.1218424110","volume":"110","author":"B-K Choi","year":"2013","unstructured":"Choi B-K, Choi M-G, Kim J-Y et al (2013) Large \u03b1-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking. Proc Natl Acad Sci U S A 110:4087\u20134092. https:\/\/doi.org\/10.1073\/pnas.1218424110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6163_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","volume":"65","author":"VM Nemani","year":"2010","unstructured":"Nemani VM, Lu W, Berge V et al (2010) Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65:66\u201379. https:\/\/doi.org\/10.1016\/j.neuron.2009.12.023","journal-title":"Neuron"},{"key":"6163_CR39","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/brain\/awq132","volume":"133","author":"P Garcia-Reitb\u00f6ck","year":"2010","unstructured":"Garcia-Reitb\u00f6ck P, Anichtchik O, Bellucci A et al (2010) SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson\u2019s disease. Brain 133:2032\u20132044. https:\/\/doi.org\/10.1093\/brain\/awq132","journal-title":"Brain"},{"key":"6163_CR40","doi-asserted-by":"publisher","first-page":"E4016","DOI":"10.1073\/pnas.1309143110","volume":"110","author":"S Janezic","year":"2013","unstructured":"Janezic S, Threlfell S, Dodson PD et al (2013) Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc Natl Acad Sci U S A 110:E4016-4025. https:\/\/doi.org\/10.1073\/pnas.1309143110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6163_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP et al (2011) Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72:57\u201371. https:\/\/doi.org\/10.1016\/j.neuron.2011.08.033","journal-title":"Neuron"},{"key":"6163_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G et al (2023) Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14. https:\/\/doi.org\/10.1038\/s41419-023-05672-9","journal-title":"Cell Death Dis"},{"key":"6163_CR43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41419-019-1364-0","volume":"10","author":"Z Lei","year":"2019","unstructured":"Lei Z, Cao G, Wei G (2019) A30P mutant \u03b1-synuclein impairs autophagic flux by inactivating JNK signaling to enhance ZKSCAN3 activity in midbrain dopaminergic neurons. Cell Death Dis 10:133. https:\/\/doi.org\/10.1038\/s41419-019-1364-0","journal-title":"Cell Death Dis"},{"key":"6163_CR44","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.expneurol.2013.03.005","volume":"247","author":"M Martinez-Vicente","year":"2013","unstructured":"Martinez-Vicente M, Vila M (2013) Alpha-synuclein and protein degradation pathways in Parkinson\u2019s disease: a pathological feed-back loop. Exp Neurol 247:308\u2013313. https:\/\/doi.org\/10.1016\/j.expneurol.2013.03.005","journal-title":"Exp Neurol"},{"key":"6163_CR45","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM, Stefanis L, Fredenburg R et al (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305:1292\u20131295. https:\/\/doi.org\/10.1126\/science.1101738","journal-title":"Science"},{"key":"6163_CR46","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1034\/j.1600-0854.2000.010707.x","volume":"1","author":"AM Cuervo","year":"2000","unstructured":"Cuervo AM, Dice JF (2000) Regulation of Lamp2a levels in the lysosomal membrane. Traffic 1:570\u2013583. https:\/\/doi.org\/10.1034\/j.1600-0854.2000.010707.x","journal-title":"Traffic"},{"key":"6163_CR47","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.nbd.2012.03.017","volume":"46","author":"KA Malkus","year":"2012","unstructured":"Malkus KA, Ischiropoulos H (2012) Regional deficiencies in chaperone-mediated autophagy underlie \u03b1-synuclein aggregation and neurodegeneration. Neurobiol Dis 46:732\u2013744. https:\/\/doi.org\/10.1016\/j.nbd.2012.03.017","journal-title":"Neurobiol Dis"},{"key":"6163_CR48","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","volume":"67","author":"L Alvarez-Erviti","year":"2010","unstructured":"Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM et al (2010) Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol 67:1464\u20131472. https:\/\/doi.org\/10.1001\/archneurol.2010.198","journal-title":"Arch Neurol"},{"key":"6163_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005515","volume":"4","author":"M Xilouri","year":"2009","unstructured":"Xilouri M, Vogiatzi T, Vekrellis K et al (2009) Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS ONE 4. https:\/\/doi.org\/10.1371\/journal.pone.0005515","journal-title":"PLoS ONE"},{"key":"6163_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04138-0","volume":"12","author":"Q Tang","year":"2021","unstructured":"Tang Q, Gao P, Arzberger T et al (2021) Alpha-Synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion. Cell Death Dis 12. https:\/\/doi.org\/10.1038\/s41419-021-04138-0","journal-title":"Cell Death Dis"},{"key":"6163_CR51","doi-asserted-by":"publisher","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","volume":"29","author":"B Spencer","year":"2009","unstructured":"Spencer B, Potkar R, Trejo M et al (2009) Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson\u2019s and Lewy body diseases. J Neurosci 29:13578\u201313588. https:\/\/doi.org\/10.1523\/JNEUROSCI.4390-09.2009","journal-title":"J Neurosci"},{"key":"6163_CR52","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00401-019-02010-2","volume":"138","author":"J Alegre-Abarrategui","year":"2019","unstructured":"Alegre-Abarrategui J, Brimblecombe KR, Roberts RF et al (2019) Selective vulnerability in \u03b1-synucleinopathies. Acta Neuropathol 138:681\u2013704. https:\/\/doi.org\/10.1007\/s00401-019-02010-2","journal-title":"Acta Neuropathol"},{"issue":"Pt 5","key":"6163_CR53","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ (1991) Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain 114(Pt 5):2283\u20132301. https:\/\/doi.org\/10.1093\/brain\/114.5.2283","journal-title":"Brain"},{"key":"6163_CR54","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ana.410270405","volume":"27","author":"GM Halliday","year":"1990","unstructured":"Halliday GM, Li YW, Blumbergs PC et al (1990) Neuropathology of immunohistochemically identified brainstem neurons in Parkinson\u2019s disease. Ann Neurol 27:373\u2013385. https:\/\/doi.org\/10.1002\/ana.410270405","journal-title":"Ann Neurol"},{"key":"6163_CR55","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s0022-510x(97)00100-7","volume":"151","author":"SY Ma","year":"1997","unstructured":"Ma SY, R\u00f6ytt\u00e4 M, Rinne JO et al (1997) Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson\u2019s disease using disector counts. J Neurol Sci 151:83\u201387. https:\/\/doi.org\/10.1016\/s0022-510x(97)00100-7","journal-title":"J Neurol Sci"},{"key":"6163_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00455","volume":"9","author":"N Gigu\u00e8re","year":"2018","unstructured":"Gigu\u00e8re N, Burke Nanni S, Trudeau L-E (2018) On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease. Front Neurol 9. https:\/\/doi.org\/10.3389\/fneur.2018.00455","journal-title":"Front Neurol"},{"key":"6163_CR57","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1523\/JNEUROSCI.4029-08.2009","volume":"29","author":"W Matsuda","year":"2009","unstructured":"Matsuda W, Furuta T, Nakamura KC et al (2009) Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci Off J Soc Neurosci 29:444\u2013453. https:\/\/doi.org\/10.1523\/JNEUROSCI.4029-08.2009","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"6163_CR58","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/mds.27823","volume":"34","author":"YC Wong","year":"2019","unstructured":"Wong YC, Luk K, Purtell K et al (2019) Neuronal vulnerability in Parkinson disease: should the focus be on axons and synaptic terminals? Mov Disord Off J Mov Disord Soc 34:1406\u20131422. https:\/\/doi.org\/10.1002\/mds.27823","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"6163_CR59","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/mds.25135","volume":"27","author":"JP Bolam","year":"2012","unstructured":"Bolam JP, Pissadaki EK (2012) Living on the edge with too many mouths to feed: why dopamine neurons die. Mov Disord Off J Mov Disord Soc 27:1478\u20131483. https:\/\/doi.org\/10.1002\/mds.25135","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"6163_CR60","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","volume":"25","author":"C Pacelli","year":"2015","unstructured":"Pacelli C, Gigu\u00e8re N, Bourque M-J et al (2015) Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons. Curr Biol CB 25:2349\u20132360. https:\/\/doi.org\/10.1016\/j.cub.2015.07.050","journal-title":"Curr Biol CB"},{"key":"6163_CR61","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla LF, Song P, Mazzulli JR et al (2017) Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science 357:1255\u20131261. https:\/\/doi.org\/10.1126\/science.aam9080","journal-title":"Science"},{"key":"6163_CR62","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nature05865","volume":"447","author":"CS Chan","year":"2007","unstructured":"Chan CS, Guzman JN, Ilijic E et al (2007) \u2018Rejuvenation\u2019 protects neurons in mouse models of Parkinson\u2019s disease. Nature 447:1081\u20131086. https:\/\/doi.org\/10.1038\/nature05865","journal-title":"Nature"},{"key":"6163_CR63","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bbrc.2016.08.168","volume":"483","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Schumacker PT, Guzman JD et al (2017) Calcium and Parkinson\u2019s disease. Biochem Biophys Res Commun 483:1013\u20131019. https:\/\/doi.org\/10.1016\/j.bbrc.2016.08.168","journal-title":"Biochem Biophys Res Commun"},{"key":"6163_CR64","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.neuroscience.2011.08.045","volume":"198","author":"DJ Surmeier","year":"2011","unstructured":"Surmeier DJ, Guzman JN, Sanchez-Padilla J, Schumacker PT (2011) The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson\u2019s disease. Neuroscience 198:221\u2013231. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.08.045","journal-title":"Neuroscience"},{"key":"6163_CR65","doi-asserted-by":"publisher","first-page":"7401","DOI":"10.1523\/JNEUROSCI.0143-10.2010","volume":"30","author":"ZM Khaliq","year":"2010","unstructured":"Khaliq ZM, Bean BP (2010) Pacemaking in dopaminergic ventral tegmental area neurons: depolarizing drive from background and voltage-dependent sodium conductances. J Neurosci 30:7401\u20137413. https:\/\/doi.org\/10.1523\/JNEUROSCI.0143-10.2010","journal-title":"J Neurosci"},{"key":"6163_CR66","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1172\/JCI95898","volume":"128","author":"JN Guzman","year":"2018","unstructured":"Guzman JN, Ilijic E, Yang B et al (2018) Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress. J Clin Invest 128:2266\u20132280. https:\/\/doi.org\/10.1172\/JCI95898","journal-title":"J Clin Invest"},{"key":"6163_CR67","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41531-025-01055-3","volume":"11","author":"L Phan","year":"2025","unstructured":"Phan L, Miller D, Gopinath A et al (2025) Parkinson\u2019s paradox: alpha-synuclein\u2019s selective strike on SNc dopamine neurons over VTA. NPJ Park Dis 11:207. https:\/\/doi.org\/10.1038\/s41531-025-01055-3","journal-title":"NPJ Park Dis"},{"key":"6163_CR68","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","volume":"72","author":"MD Weingarten","year":"1975","unstructured":"Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A 72:1858\u20131862. https:\/\/doi.org\/10.1073\/pnas.72.5.1858","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6163_CR69","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/j.cub.2018.05.045","volume":"28","author":"L Qiang","year":"2018","unstructured":"Qiang L, Sun X, Austin TO et al (2018) Tau does not stabilize axonal microtubules but rather enables them to have long labile domains. Curr Biol 28:2181-2189.e4. https:\/\/doi.org\/10.1016\/j.cub.2018.05.045","journal-title":"Curr Biol"},{"key":"6163_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00533-z","volume":"17","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wu K-M, Yang L et al (2022) Tauopathies: new perspectives and challenges. Mol Neurodegener 17. https:\/\/doi.org\/10.1186\/s13024-022-00533-z","journal-title":"Mol Neurodegener"},{"key":"6163_CR71","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.2353\/ajpath.2006.050840","volume":"168","author":"TL Spires","year":"2006","unstructured":"Spires TL, Orne JD, SantaCruz K et al (2006) Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am J Pathol 168:1598\u20131607. https:\/\/doi.org\/10.2353\/ajpath.2006.050840","journal-title":"Am J Pathol"},{"key":"6163_CR72","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1523\/JNEUROSCI.5245-10.2011","volume":"31","author":"A Sydow","year":"2011","unstructured":"Sydow A, Van der Jeugd A, Zheng F et al (2011) Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant. J Neurosci 31:2511\u20132525. https:\/\/doi.org\/10.1523\/JNEUROSCI.5245-10.2011","journal-title":"J Neurosci"},{"key":"6163_CR73","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1326-6-39","volume":"6","author":"CA Lasagna-Reeves","year":"2011","unstructured":"Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U et al (2011) Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol Neurodegener 6:39. https:\/\/doi.org\/10.1186\/1750-1326-6-39","journal-title":"Mol Neurodegener"},{"key":"6163_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00338","volume":"12","author":"AD Alonso","year":"2018","unstructured":"Alonso AD, Cohen LS, Corbo C et al (2018) Hyperphosphorylation of tau associates with changes in its function beyond microtubule stability. Front Cell Neurosci 12. https:\/\/doi.org\/10.3389\/fncel.2018.00338","journal-title":"Front Cell Neurosci"},{"key":"6163_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00204","author":"P Barbier","year":"2019","unstructured":"Barbier P, Zejneli O, Martinho M et al (2019) Role of tau as a microtubule-associated protein: structural and functional aspects. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2019.00204","journal-title":"Front Aging Neurosci"},{"key":"6163_CR76","doi-asserted-by":"publisher","first-page":"6923","DOI":"10.1073\/pnas.121119298","volume":"98","author":"A Alonso","year":"2001","unstructured":"Alonso A, Zaidi T, Novak M et al (2001) Hyperphosphorylation induces self-assembly of \u03c4 into tangles of paired helical filaments\/straight filaments. Proc Natl Acad Sci U S A 98:6923\u20136928. https:\/\/doi.org\/10.1073\/pnas.121119298","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6163_CR77","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1073\/pnas.94.1.298","volume":"94","author":"A Alonso","year":"1997","unstructured":"Alonso A, Grundke-Iqbal I, Barra HS, Iqbal K (1997) Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci U S A 94:298\u2013303. https:\/\/doi.org\/10.1073\/pnas.94.1.298","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6163_CR78","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nm0796-783","volume":"2","author":"AC Alonso","year":"1996","unstructured":"Alonso AC, Grundke-Iqbal I, Iqbal K (1996) Alzheimer\u2019s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 2:783\u2013787. https:\/\/doi.org\/10.1038\/nm0796-783","journal-title":"Nat Med"},{"key":"6163_CR79","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.neurobiolaging.2003.04.007","volume":"24","author":"E Mandelkow","year":"2003","unstructured":"Mandelkow E, Stamer K, Vogel R et al (2003) Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol Aging 24:1079\u20131085. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2003.04.007","journal-title":"Neurobiol Aging"},{"key":"6163_CR80","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13024-017-0199-3","volume":"12","author":"M Chiasseu","year":"2017","unstructured":"Chiasseu M, Alarcon-Martinez L, Belforte N et al (2017) Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer\u2019s disease. Mol Neurodegener 12:58. https:\/\/doi.org\/10.1186\/s13024-017-0199-3","journal-title":"Mol Neurodegener"},{"key":"6163_CR81","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.ajpath.2011.07.004","volume":"179","author":"KJ Kopeikina","year":"2011","unstructured":"Kopeikina KJ, Carlson GA, Pitstick R et al (2011) Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer\u2019s disease brain. Am J Pathol 179:2071\u20132082. https:\/\/doi.org\/10.1016\/j.ajpath.2011.07.004","journal-title":"Am J Pathol"},{"key":"6163_CR82","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1523\/JNEUROSCI.5927-11.2012","volume":"32","author":"K Shahpasand","year":"2012","unstructured":"Shahpasand K, Uemura I, Saito T et al (2012) Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer\u2019s disease. J Neurosci 32:2430\u20132441. https:\/\/doi.org\/10.1523\/JNEUROSCI.5927-11.2012","journal-title":"J Neurosci"},{"key":"6163_CR83","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1083\/jcb.143.3.777","volume":"143","author":"A Ebneth","year":"1998","unstructured":"Ebneth A, Godemann R, Stamer K et al (1998) Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer\u2019s disease. J Cell Biol 143:777\u2013794. https:\/\/doi.org\/10.1083\/jcb.143.3.777","journal-title":"J Cell Biol"},{"key":"6163_CR84","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239\u2013259. https:\/\/doi.org\/10.1007\/BF00308809","journal-title":"Acta Neuropathol (Berl)"},{"key":"6163_CR85","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera F, Bolmont T, Crowther RA et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909\u2013913. https:\/\/doi.org\/10.1038\/ncb1901","journal-title":"Nat Cell Biol"},{"key":"6163_CR86","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/cne.903010105","volume":"301","author":"PR Hof","year":"1990","unstructured":"Hof PR, Morrison JH, Cox K (1990) Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer\u2019s disease: I. Superior frontal and inferior temporal cortex. J Comp Neurol 301:44\u201354. https:\/\/doi.org\/10.1002\/cne.903010105","journal-title":"J Comp Neurol"},{"key":"6163_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115758","volume":"44","author":"G Lin","year":"2025","unstructured":"Lin G, Chancellor SE, Kwon T et al (2025) Cell-death pathways and tau-associated neuronal vulnerability in Alzheimer\u2019s disease. Cell Rep 44. https:\/\/doi.org\/10.1016\/j.celrep.2025.115758","journal-title":"Cell Rep"},{"key":"6163_CR88","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.neuron.2023.02.033","volume":"111","author":"R Praschberger","year":"2023","unstructured":"Praschberger R, Kuenen S, Schoovaerts N et al (2023) Neuronal identity defines \u03b1-synuclein and tau toxicity. Neuron 111:1577-1590.e11. https:\/\/doi.org\/10.1016\/j.neuron.2023.02.033","journal-title":"Neuron"},{"key":"6163_CR89","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1093\/brain\/awae051","volume":"147","author":"P Rodriguez-Rodriguez","year":"2024","unstructured":"Rodriguez-Rodriguez P, Arroyo-Garcia LE, Tsagkogianni C et al (2024) A cell autonomous regulator of neuronal excitability modulates tau in Alzheimer\u2019s disease vulnerable neurons. Brain 147:2384\u20132399. https:\/\/doi.org\/10.1093\/brain\/awae051","journal-title":"Brain"},{"key":"6163_CR90","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaf179","author":"C Anand","year":"2025","unstructured":"Anand C, Abdelnour F, Sipes B et al (2025) Selective vulnerability and resilience to Alzheimer\u2019s disease tauopathy as a function of genes and the connectome. Brain. https:\/\/doi.org\/10.1093\/brain\/awaf179","journal-title":"Brain"},{"key":"6163_CR91","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s42003-025-07575-1","volume":"8","author":"J Torok","year":"2025","unstructured":"Torok J, Maia PD, Anand C, Raj A (2025) Searching for the cellular underpinnings of the selective vulnerability to tauopathic insults in Alzheimer\u2019s disease. Commun Biol 8:195. https:\/\/doi.org\/10.1038\/s42003-025-07575-1","journal-title":"Commun Biol"},{"key":"6163_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158338","volume":"22","author":"A Jan","year":"2021","unstructured":"Jan A, Gon\u00e7alves NP, Vaegter CB et al (2021) The prion-like spreading of alpha-synuclein in Parkinson\u2019s disease: update on models and hypotheses. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms22158338","journal-title":"Int J Mol Sci"},{"key":"6163_CR93","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.biopsych.2017.04.003","volume":"83","author":"JI Ayers","year":"2018","unstructured":"Ayers JI, Giasson BI, Borchelt DR (2018) Prion-like spreading in tauopathies. Biol Psychiatry 83:337\u2013346. https:\/\/doi.org\/10.1016\/j.biopsych.2017.04.003","journal-title":"Biol Psychiatry"},{"key":"6163_CR94","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.tins.2010.04.003","volume":"33","author":"M Goedert","year":"2010","unstructured":"Goedert M, Clavaguera F, Tolnay M (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33:317\u2013325. https:\/\/doi.org\/10.1016\/j.tins.2010.04.003","journal-title":"Trends Neurosci"},{"key":"6163_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-15-69","volume":"15","author":"S Auli\u0107","year":"2014","unstructured":"Auli\u0107 S, Le TTN, Moda F et al (2014) Defined \u03b1-synuclein prion-like molecular assemblies spreading in cell culture. BMC Neurosci 15. https:\/\/doi.org\/10.1186\/1471-2202-15-69","journal-title":"BMC Neurosci"},{"key":"6163_CR96","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk KC, Song C, O\u2019Brien P et al (2009) Exogenous \u03b1-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A 106:20051\u201320056. https:\/\/doi.org\/10.1073\/pnas.0908005106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6163_CR97","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm VM, Zhang B et al (2012) Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice. J Exp Med 209:975\u2013986. https:\/\/doi.org\/10.1084\/jem.20112457","journal-title":"J Exp Med"},{"key":"6163_CR98","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","volume":"138","author":"N Van Den Berge","year":"2019","unstructured":"Van Den Berge N, Ferreira N, Gram H et al (2019) Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta Neuropathol 138:535\u2013550. https:\/\/doi.org\/10.1007\/s00401-019-02040-w","journal-title":"Acta Neuropathol"},{"key":"6163_CR99","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA et al (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat Med 14:504\u2013506. https:\/\/doi.org\/10.1038\/nm1747","journal-title":"Nat Med"},{"key":"6163_CR100","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"J-Y Li","year":"2008","unstructured":"Li J-Y, Englund E, Holton JL et al (2008) Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med 14:501\u2013503. https:\/\/doi.org\/10.1038\/nm1746","journal-title":"Nat Med"},{"key":"6163_CR101","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02095-16","volume":"91","author":"JI Ayers","year":"2017","unstructured":"Ayers JI, Brooks MM, Rutherford NJ et al (2017) Robust central nervous system pathology in transgenic mice following peripheral injection of \u03b1-synuclein fibrils. J Virol 91. https:\/\/doi.org\/10.1128\/JVI.02095-16","journal-title":"J Virol"},{"key":"6163_CR102","doi-asserted-by":"publisher","first-page":"9182","DOI":"10.1128\/JVI.01399-16","volume":"90","author":"S Breid","year":"2016","unstructured":"Breid S, Bernis ME, Babila JT et al (2016) Neuroinvasion of \u03b1-synuclein prionoids after intraperitoneal and intraglossal inoculation. J Virol 90:9182\u20139193. https:\/\/doi.org\/10.1128\/JVI.01399-16","journal-title":"J Virol"},{"key":"6163_CR103","doi-asserted-by":"publisher","first-page":"12845","DOI":"10.1074\/jbc.M808759200","volume":"284","author":"B Frost","year":"2009","unstructured":"Frost B, Jacks RL, Diamond MI (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284:12845\u201312852. https:\/\/doi.org\/10.1074\/jbc.M808759200","journal-title":"J Biol Chem"},{"key":"6163_CR104","doi-asserted-by":"publisher","first-page":"19440","DOI":"10.1074\/jbc.M112.346072","volume":"287","author":"N Kfoury","year":"2012","unstructured":"Kfoury N, Holmes BB, Jiang H et al (2012) Trans-cellular propagation of tau aggregation by fibrillar species. J Biol Chem 287:19440\u201319451. https:\/\/doi.org\/10.1074\/jbc.M112.346072","journal-title":"J Biol Chem"},{"key":"6163_CR105","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","volume":"73","author":"A de Calignon","year":"2012","unstructured":"de Calignon A, Polydoro M, Su\u00e1rez-Calvet M et al (2012) Propagation of tau pathology in a model of early Alzheimer\u2019s disease. Neuron 73:685\u2013697. https:\/\/doi.org\/10.1016\/j.neuron.2011.11.033","journal-title":"Neuron"},{"key":"6163_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031302","volume":"7","author":"L Liu","year":"2012","unstructured":"Liu L, Drouet V, Wu JW et al (2012) Trans-synaptic spread of tau pathology in vivo. PLoS ONE 7. https:\/\/doi.org\/10.1371\/journal.pone.0031302","journal-title":"PLoS ONE"},{"key":"6163_CR107","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","volume":"82","author":"DW Sanders","year":"2014","unstructured":"Sanders DW, Kaufman SK, DeVos SL et al (2014) Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82:1271\u20131288. https:\/\/doi.org\/10.1016\/j.neuron.2014.04.047","journal-title":"Neuron"},{"key":"6163_CR108","doi-asserted-by":"publisher","unstructured":"Hromadkova L, Kim C, Haldiman T, et al (2023) Evolving prion-like tau conformers differentially alter postsynaptic proteins in neurons inoculated with distinct isolates of Alzheimer\u2019s disease tau. Cell Amp Biosci 13:NA-NA. https:\/\/doi.org\/10.1186\/s13578-023-01133-0","DOI":"10.1186\/s13578-023-01133-0"},{"key":"6163_CR109","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1242\/jcs.180737","volume":"129","author":"PR Angelova","year":"2016","unstructured":"Angelova PR, Ludtmann MHR, Horrocks MH et al (2016) Ca2+ is a key factor in \u03b1-synuclein-induced neurotoxicity. J Cell Sci 129:1792\u20131801. https:\/\/doi.org\/10.1242\/jcs.180737","journal-title":"J Cell Sci"},{"key":"6163_CR110","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","volume":"27","author":"KM Danzer","year":"2007","unstructured":"Danzer KM, Haasen D, Karow AR et al (2007) Different species of \u03b1-synuclein oligomers induce calcium influx and seeding. J Neurosci 27:9220\u20139232. https:\/\/doi.org\/10.1523\/JNEUROSCI.2617-07.2007","journal-title":"J Neurosci"},{"key":"6163_CR111","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/jnc.13060","volume":"132","author":"CR Pacheco","year":"2015","unstructured":"Pacheco CR, Morales CN, Ram\u00edrez AE et al (2015) Extracellular \u03b1-synuclein alters synaptic transmission in brain neurons by perforating the neuronal plasma membrane. J Neurochem 132:731\u2013741. https:\/\/doi.org\/10.1111\/jnc.13060","journal-title":"J Neurochem"},{"key":"6163_CR112","doi-asserted-by":"publisher","unstructured":"Betzer C, Lassen LB, Olsen A, et al (2018) Alpha\u2010synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation. EMBO Rep 19:e44617. https:\/\/doi.org\/10.15252\/embr.201744617","DOI":"10.15252\/embr.201744617"},{"key":"6163_CR113","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neuroscience.2015.05.035","volume":"300","author":"Y Chen","year":"2015","unstructured":"Chen Y, Yang W, Li X et al (2015) \u03b1-Synuclein-induced internalization of NMDA receptors in hippocampal neurons is associated with reduced inward current and Ca2+ influx upon NMDA stimulation. Neuroscience 300:297\u2013306. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.05.035","journal-title":"Neuroscience"},{"key":"6163_CR114","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1002\/glia.23472","volume":"66","author":"M dos\u2010Santos\u2010Pereira","year":"2018","unstructured":"dos\u2010Santos\u2010Pereira M, Acu\u00f1a L, Hamadat S et al (2018) Microglial glutamate release evoked by \u03b1\u2010synuclein aggregates is prevented by dopamine. Glia 66:2353\u20132365. https:\/\/doi.org\/10.1002\/glia.23472","journal-title":"Glia"},{"key":"6163_CR115","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1523\/JNEUROSCI.1871-20.2020","volume":"41","author":"D Trudler","year":"2021","unstructured":"Trudler D, Sanz-Blasco S, Eisele YS et al (2021) \u03b1-Synuclein oligomers induce glutamate release from astrocytes and excessive extrasynaptic NMDAR activity in neurons, thus contributing to synapse loss. J Neurosci 41:2264\u20132273. https:\/\/doi.org\/10.1523\/JNEUROSCI.1871-20.2020","journal-title":"J Neurosci"},{"key":"6163_CR116","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/pnas.0511065103","volume":"103","author":"G Amadoro","year":"2006","unstructured":"Amadoro G, Ciotti MT, Costanzi M et al (2006) NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK\/MAPK activation. Proc Natl Acad Sci U S A 103:2892\u20132897. https:\/\/doi.org\/10.1073\/pnas.0511065103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6163_CR117","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/febs.15340","volume":"288","author":"N Esteras","year":"2021","unstructured":"Esteras N, Kundel F, Amodeo GF et al (2021) Insoluble tau aggregates induce neuronal death through modification of membrane ion conductance, activation of voltage\u2010gated calcium channels and NADPH oxidase. FEBS J 288:127\u2013141. https:\/\/doi.org\/10.1111\/febs.15340","journal-title":"FEBS J"},{"key":"6163_CR118","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1471-4159.2003.02020.x","volume":"87","author":"K Furukawa","year":"2003","unstructured":"Furukawa K, Wang Y, Yao PJ et al (2003) Alteration in calcium channel properties is responsible for the neurotoxic action of a familial frontotemporal dementia tau mutation. J Neurochem 87:427\u2013436. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.02020.x","journal-title":"J Neurochem"},{"key":"6163_CR119","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-017-0176-x","volume":"12","author":"T Miyamoto","year":"2017","unstructured":"Miyamoto T, Stein L, Thomas R et al (2017) Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture. Mol Neurodegener 12:41. https:\/\/doi.org\/10.1186\/s13024-017-0176-x","journal-title":"Mol Neurodegener"},{"key":"6163_CR120","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12811","volume":"48","author":"DD Li Puma","year":"2022","unstructured":"Li Puma DD, Ripoli C, Puliatti G et al (2022) Extracellular tau oligomers affect extracellular glutamate handling by astrocytes through downregulation of GLT\u20101 expression and impairment of NKA1A2 function. Neuropathol Appl Neurobiol 48. https:\/\/doi.org\/10.1111\/nan.12811","journal-title":"Neuropathol Appl Neurobiol"},{"key":"6163_CR121","doi-asserted-by":"publisher","first-page":"552","DOI":"10.15252\/embr.201541439","volume":"17","author":"JM Decker","year":"2016","unstructured":"Decker JM, Kr\u00fcger L, Sydow A et al (2016) The Tau\/A152T mutation, a risk factor for frontotemporal\u2010spectrum disorders, leads to NR2B receptor\u2010mediated excitotoxicity. EMBO Rep 17:552\u2013569. https:\/\/doi.org\/10.15252\/embr.201541439","journal-title":"EMBO Rep"},{"key":"6163_CR122","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/jnc.13230","volume":"135","author":"HC Hunsberger","year":"2015","unstructured":"Hunsberger HC, Weitzner DS, Rudy CC et al (2015) Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression. J Neurochem 135:381\u2013394. https:\/\/doi.org\/10.1111\/jnc.13230","journal-title":"J Neurochem"},{"key":"6163_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2022.12.006","volume":"154","author":"F Bearoff","year":"2023","unstructured":"Bearoff F, Dhavale D, Kotzbauer P, Kortagere S (2023) Aggregated alpha-synuclein transcriptionally activates pro-inflammatory canonical and non-canonical NF-\u03baB signaling pathways in peripheral monocytic cells. Mol Immunol 154:1\u201310. https:\/\/doi.org\/10.1016\/j.molimm.2022.12.006","journal-title":"Mol Immunol"},{"key":"6163_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/glia.24626","author":"J Niskanen","year":"2024","unstructured":"Niskanen J, Peltonen S, Ohtonen S et al (2024) Uptake of alpha\u2010synuclein preformed fibrils is suppressed by inflammation and induces an aberrant phenotype in human microglia. Glia. https:\/\/doi.org\/10.1002\/glia.24626","journal-title":"Glia"},{"key":"6163_CR125","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1084\/jem.20182191","volume":"216","author":"N Panicker","year":"2019","unstructured":"Panicker N, Sarkar S, Harischandra DS et al (2019) Fyn kinase regulates misfolded \u03b1-synuclein uptake and NLRP3 inflammasome activation in microglia. J Exp Med 216:1411\u20131430. https:\/\/doi.org\/10.1084\/jem.20182191","journal-title":"J Exp Med"},{"key":"6163_CR126","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12868-015-0192-0","volume":"16","author":"EH Rannikko","year":"2015","unstructured":"Rannikko EH, Weber SS, Kahle PJ (2015) Exogenous \u03b1-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes. BMC Neurosci 16:57. https:\/\/doi.org\/10.1186\/s12868-015-0192-0","journal-title":"BMC Neurosci"},{"key":"6163_CR127","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"H-J Lee","year":"2010","unstructured":"Lee H-J, Suk J-E, Patrick C et al (2010) Direct transfer of \u03b1-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 285:9262\u20139272. https:\/\/doi.org\/10.1074\/jbc.M109.081125","journal-title":"J Biol Chem"},{"key":"6163_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03043-5","volume":"21","author":"C Yildirim-Balatan","year":"2024","unstructured":"Yildirim-Balatan C, Fenyi A, Besnault P et al (2024) Parkinson\u2019s disease-derived \u03b1-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype. J Neuroinflammation 21. https:\/\/doi.org\/10.1186\/s12974-024-03043-5","journal-title":"J Neuroinflammation"},{"key":"6163_CR129","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.neures.2020.11.004","volume":"170","author":"M Izco","year":"2021","unstructured":"Izco M, Blesa J, Verona G et al (2021) Glial activation precedes alpha-synuclein pathology in a mouse model of Parkinson\u2019s disease. Neurosci Res 170:330\u2013340. https:\/\/doi.org\/10.1016\/j.neures.2020.11.004","journal-title":"Neurosci Res"},{"key":"6163_CR130","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-018-1171-z","volume":"15","author":"MF Duffy","year":"2018","unstructured":"Duffy MF, Collier TJ, Patterson JR et al (2018) Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration. J Neuroinflammation 15:129. https:\/\/doi.org\/10.1186\/s12974-018-1171-z","journal-title":"J Neuroinflammation"},{"key":"6163_CR131","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/glia.23338","volume":"66","author":"S Castro-S\u00e1nchez","year":"2018","unstructured":"Castro-S\u00e1nchez S, Garc\u00eda-Yag\u00fce \u00c1J, L\u00f3pez-Royo T et al (2018) Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease. Glia 66:1752\u20131762. https:\/\/doi.org\/10.1002\/glia.23338","journal-title":"Glia"},{"key":"6163_CR132","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161987","volume":"133","author":"D Dutta","year":"2023","unstructured":"Dutta D, Jana M, Paidi RK et al (2023) Tau fibrils induce glial inflammation and neuropathology via TLR2 in Alzheimer\u2019s disease\u2013related mouse models. J Clin Invest 133. https:\/\/doi.org\/10.1172\/JCI161987","journal-title":"J Clin Invest"},{"key":"6163_CR133","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10753-018-0735-5","volume":"41","author":"T Jiang","year":"2018","unstructured":"Jiang T, Zhang Y-D, Gao Q et al (2018) TREM2 ameliorates neuronal tau pathology through suppression of microglial inflammatory response. Inflammation 41:811\u2013823. https:\/\/doi.org\/10.1007\/s10753-018-0735-5","journal-title":"Inflammation"},{"key":"6163_CR134","doi-asserted-by":"publisher","first-page":"NA","DOI":"10.1186\/s40478-024-01745-8","volume":"12","author":"K Eltom","year":"2024","unstructured":"Eltom K, Mothes T, Libard S et al (2024) Astrocytic accumulation of tau fibrils isolated from Alzheimer\u2019s disease brains induces inflammation, cell-to-cell propagation and neuronal impairment. Acta Neuropathol Commun 12:NA-NA. https:\/\/doi.org\/10.1186\/s40478-024-01745-8","journal-title":"Acta Neuropathol Commun"},{"key":"6163_CR135","doi-asserted-by":"publisher","unstructured":"Wang P, Yihong Y (2021) Filamentous recombinant human tau activates primary astrocytes via an integrin receptor complex. Nat Commun 12:. https:\/\/doi.org\/10.1038\/s41467-020-20322-w","DOI":"10.1038\/s41467-020-20322-w"},{"key":"6163_CR136","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y, Higuchi M, Zhang B et al (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53:337\u2013351. https:\/\/doi.org\/10.1016\/j.neuron.2007.01.010","journal-title":"Neuron"},{"key":"6163_CR137","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neurobiolaging.2020.01.003","volume":"89","author":"L van Olst","year":"2020","unstructured":"van Olst L, Verhaege D, Franssen M et al (2020) Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model. Neurobiol Aging 89:89\u201398. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.01.003","journal-title":"Neurobiol Aging"},{"key":"6163_CR138","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","volume":"68","author":"K Bhaskar","year":"2010","unstructured":"Bhaskar K, Konerth M, Kokiko-Cochran ON et al (2010) Regulation of tau pathology by the microglial fractalkine receptor. Neuron 68:19\u201331. https:\/\/doi.org\/10.1016\/j.neuron.2010.08.023","journal-title":"Neuron"},{"key":"6163_CR139","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.4049\/jimmunol.1100620","volume":"187","author":"M Kitazawa","year":"2011","unstructured":"Kitazawa M, Cheng D, Tsukamoto MR et al (2011) Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal \u03b2-catenin pathway function in an Alzheimer\u2019s disease model. J Immunol 187:6539\u20136549. https:\/\/doi.org\/10.4049\/jimmunol.1100620","journal-title":"J Immunol"},{"key":"6163_CR140","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","volume":"157","author":"LJ Hsu","year":"2000","unstructured":"Hsu LJ, Sagara Y, Arroyo A et al (2000) \u03b1-Synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 157:401\u2013410. https:\/\/doi.org\/10.1016\/S0002-9440(10)64553-1","journal-title":"Am J Pathol"},{"key":"6163_CR141","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1007\/s00018-017-2541-x","volume":"74","author":"V Tapias","year":"2017","unstructured":"Tapias V, Hu X, Luk KC et al (2017) Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production. Cell Mol Life Sci 74:2851\u20132874. https:\/\/doi.org\/10.1007\/s00018-017-2541-x","journal-title":"Cell Mol Life Sci"},{"key":"6163_CR142","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","volume":"9","author":"MHR Ludtmann","year":"2018","unstructured":"Ludtmann MHR, Angelova PR, Horrocks MH et al (2018) \u03b1-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease. Nat Commun 9:2293. https:\/\/doi.org\/10.1038\/s41467-018-04422-2","journal-title":"Nat Commun"},{"key":"6163_CR143","doi-asserted-by":"publisher","first-page":"21490","DOI":"10.1074\/jbc.M113.545749","volume":"289","author":"ES Luth","year":"2014","unstructured":"Luth ES, Stavrovskaya IG, Bartels T et al (2014) Soluble, prefibrillar \u03b1-synuclein oligomers promote complex I-dependent, Ca2+-induced mitochondrial dysfunction. J Biol Chem 289:21490\u201321507. https:\/\/doi.org\/10.1074\/jbc.M113.545749","journal-title":"J Biol Chem"},{"key":"6163_CR144","doi-asserted-by":"publisher","first-page":"342ra78","DOI":"10.1126\/scitranslmed.aaf3634","volume":"8","author":"R Di Maio","year":"2016","unstructured":"Di Maio R, Barrett PJ, Hoffman EK et al (2016) \u03b1-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease. Sci Transl Med 8:342ra78. https:\/\/doi.org\/10.1126\/scitranslmed.aaf3634","journal-title":"Sci Transl Med"},{"key":"6163_CR145","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1523\/JNEUROSCI.0089-14.2015","volume":"35","author":"L Chen","year":"2015","unstructured":"Chen L, Xie Z, Turkson S, Zhuang X (2015) A53T human \u03b1-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration. J Neurosci 35:890\u2013905. https:\/\/doi.org\/10.1523\/JNEUROSCI.0089-14.2015","journal-title":"J Neurosci"},{"key":"6163_CR146","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neulet.2010.09.061","volume":"486","author":"SJ Chinta","year":"2010","unstructured":"Chinta SJ, Mallajosyula JK, Rane A, Andersen JK (2010) Mitochondrial \u03b1-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci Lett 486:235\u2013239. https:\/\/doi.org\/10.1016\/j.neulet.2010.09.061","journal-title":"Neurosci Lett"},{"key":"6163_CR147","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.nbd.2014.06.017","volume":"70","author":"SR Subramaniam","year":"2014","unstructured":"Subramaniam SR, Vergnes L, Franich NR et al (2014) Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein. Neurobiol Dis 70:204\u2013213. https:\/\/doi.org\/10.1016\/j.nbd.2014.06.017","journal-title":"Neurobiol Dis"},{"key":"6163_CR148","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1016\/j.bbadis.2018.07.011","volume":"1864","author":"D Cieri","year":"2018","unstructured":"Cieri D, Vicario M, Vallese F et al (2018) Tau localises within mitochondrial sub-compartments and its caspase cleavage affects ER-mitochondria interactions and cellular Ca2+ handling. Biochimica et Biophysica Acta (BBA) 1864:3247\u20133256. https:\/\/doi.org\/10.1016\/j.bbadis.2018.07.011","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"6163_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166898","volume":"1870","author":"MJ P\u00e9rez","year":"2024","unstructured":"P\u00e9rez MJ, Ibarra-Garc\u00eda-Padilla R, Tang M et al (2024) Caspase-3 cleaved tau impairs mitochondrial function through the opening of the mitochondrial permeability transition pore. Biochimica et Biophysica Acta (BBA) 1870. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166898","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"6163_CR150","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899360","author":"N Cummins","year":"2019","unstructured":"Cummins N, Tweedie A, Zuryn S et al (2019) Disease\u2010associated tau impairs mitophagy by inhibiting Parkin translocation to mitochondria. EMBO J. https:\/\/doi.org\/10.15252\/embj.201899360","journal-title":"EMBO J"},{"key":"6163_CR151","doi-asserted-by":"publisher","first-page":"24756","DOI":"10.1038\/srep24756","volume":"6","author":"X Li","year":"2016","unstructured":"Li X, Hu Y, Wang Z et al (2016) Human wild-type full-length tau accumulation disrupts mitochondrial dynamics and the functions via increasing mitofusins. Sci Rep Nat Publ Group 6:24756. https:\/\/doi.org\/10.1038\/srep24756","journal-title":"Sci Rep Nat Publ Group"},{"key":"6163_CR152","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.neuron.2012.06.026","volume":"75","author":"B DuBoff","year":"2012","unstructured":"DuBoff B, G\u00f6tz J, Feany MB (2012) Tau promotes neurodegeneration via DRP1 mislocalization in vivo. Neuron 75:618\u2013632. https:\/\/doi.org\/10.1016\/j.neuron.2012.06.026","journal-title":"Neuron"},{"key":"6163_CR153","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1093\/hmg\/dds072","volume":"21","author":"M Manczak","year":"2012","unstructured":"Manczak M, Reddy PH (2012) Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer\u2019s disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum Mol Genet 21:2538\u20132547. https:\/\/doi.org\/10.1093\/hmg\/dds072","journal-title":"Hum Mol Genet"},{"key":"6163_CR154","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neurobiolaging.2024.12.006","volume":"147","author":"L Daniel Estrella","year":"2025","unstructured":"Daniel Estrella L, Trease AJ, Sheldon L et al (2025) Tau association with synaptic mitochondria coincides with energetic dysfunction and excitatory synapse loss in the P301S tauopathy mouse model. Neurobiol Aging 147:163\u2013175. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2024.12.006","journal-title":"Neurobiol Aging"},{"key":"6163_CR155","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/15548627.2024.2392408","volume":"21","author":"N Jia","year":"2024","unstructured":"Jia N, Ganesan D, Guan H et al (2024) Mitochondrial bioenergetics stimulates autophagy for pathological MAPT\/Tau clearance in tauopathy neurons. Autophagy 21:54\u201379. https:\/\/doi.org\/10.1080\/15548627.2024.2392408","journal-title":"Autophagy"},{"key":"6163_CR156","doi-asserted-by":"publisher","unstructured":"Szabo L, Cummins N, Paganetti P, et al (2023) ER\u2010mitochondria contacts and cholesterol metabolism are disrupted by disease\u2010associated tau protein. EMBO Rep 24:e57499. https:\/\/doi.org\/10.15252\/embr.202357499","DOI":"10.15252\/embr.202357499"},{"key":"6163_CR157","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Sim\u00f3n-S\u00e1nchez","year":"2009","unstructured":"Sim\u00f3n-S\u00e1nchez J, Schulte C, Bras JM et al (2009) Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet 41:1308\u20131312. https:\/\/doi.org\/10.1038\/ng.487","journal-title":"Nat Genet"},{"key":"6163_CR158","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1469-1809.2009.00560.x","volume":"74","author":"TL Edwards","year":"2010","unstructured":"Edwards TL, Scott WK, Almonte C et al (2010) Genome\u2010wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 74:97\u2013109. https:\/\/doi.org\/10.1111\/j.1469-1809.2009.00560.x","journal-title":"Ann Hum Genet"},{"key":"6163_CR159","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ana.22321","volume":"69","author":"A Elbaz","year":"2011","unstructured":"Elbaz A, Ross OA, Ioannidis JPA et al (2011) Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol 69:778\u2013792. https:\/\/doi.org\/10.1002\/ana.22321","journal-title":"Ann Neurol"},{"key":"6163_CR160","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/jnnp.2003.026203","volume":"75","author":"DG Healy","year":"2004","unstructured":"Healy DG, Abou-Sleiman PM, Lees AJ et al (2004) Tau gene and Parkinson\u2019s disease: a case-control study and meta-analysis. J Neurol Neurosurg Psychiatry 75:962\u2013965. https:\/\/doi.org\/10.1136\/jnnp.2003.026203","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6163_CR161","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s0304-3940(02)00106-4","volume":"322","author":"M Farrer","year":"2002","unstructured":"Farrer M, Skipper L, Berg M et al (2002) The tau H1 haplotype is associated with Parkinson\u2019s disease in the Norwegian population. Neurosci Lett 322:83\u201386. https:\/\/doi.org\/10.1016\/s0304-3940(02)00106-4","journal-title":"Neurosci Lett"},{"key":"6163_CR162","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.parkreldis.2021.09.008","volume":"90","author":"E Leveille","year":"2021","unstructured":"Leveille E, Ross OA, Gan-Or Z (2021) Tau and MAPT genetics in tauopathies and synucleinopathies. Parkinsonism Relat Disord 90:142\u2013154. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.09.008","journal-title":"Parkinsonism Relat Disord"},{"key":"6163_CR163","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40478-023-01534-9","volume":"11","author":"CV Tauber","year":"2023","unstructured":"Tauber CV, Schwarz SC, R\u00f6sler TW et al (2023) Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue. Acta Neuropathol Commun 11:40. https:\/\/doi.org\/10.1186\/s40478-023-01534-9","journal-title":"Acta Neuropathol Commun"},{"key":"6163_CR164","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/ana.21192","volume":"62","author":"A Goris","year":"2007","unstructured":"Goris A, Williams\u2010Gray CH, Clark GR et al (2007) Tau and \u03b1\u2010synuclein in susceptibility to, and dementia in, Parkinson\u2019s disease. Ann Neurol 62:145\u2013153. https:\/\/doi.org\/10.1002\/ana.21192","journal-title":"Ann Neurol"},{"key":"6163_CR165","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1001\/archneurol.2011.17","volume":"68","author":"N Set\u00f3-Salvia","year":"2011","unstructured":"Set\u00f3-Salvia N, Clarim\u00f3n J, Pagonabarraga J et al (2011) Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes. Arch Neurol 68:359\u2013364. https:\/\/doi.org\/10.1001\/archneurol.2011.17","journal-title":"Arch Neurol"},{"key":"6163_CR166","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.neurobiolaging.2014.12.006","volume":"36","author":"SE Winder-Rhodes","year":"2015","unstructured":"Winder-Rhodes SE, Hampshire A, Rowe JB et al (2015) Association between MAPT haplotype and memory function in patients with Parkinson\u2019s disease and healthy aging individuals. Neurobiol Aging 36:1519\u20131528. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.12.006","journal-title":"Neurobiol Aging"},{"key":"6163_CR167","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/mds.24946","volume":"27","author":"JF Morley","year":"2012","unstructured":"Morley JF, Xie SX, Hurtig HI et al (2012) Genetic influences on cognitive decline in Parkinson\u2019s disease. Mov Disord 27:512\u2013518. https:\/\/doi.org\/10.1002\/mds.24946","journal-title":"Mov Disord"},{"key":"6163_CR168","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1212\/WNL.0000000000000066","volume":"82","author":"AJ Yarnall","year":"2014","unstructured":"Yarnall AJ, Breen DP, Duncan GW et al (2014) Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology 82:308\u2013316. https:\/\/doi.org\/10.1212\/WNL.0000000000000066","journal-title":"Neurology"},{"key":"6163_CR169","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.neurobiolaging.2016.09.001","volume":"48","author":"T Rittman","year":"2016","unstructured":"Rittman T, Rubinov M, V\u00e9rtes PE et al (2016) Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy. Neurobiol Aging 48:153\u2013160. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.09.001","journal-title":"Neurobiol Aging"},{"key":"6163_CR170","doi-asserted-by":"publisher","first-page":"7470","DOI":"10.1074\/jbc.RA119.012284","volume":"295","author":"J Lu","year":"2020","unstructured":"Lu J, Zhang S, Ma X et al (2020) Structural basis of the interplay between \u03b1-synuclein and Tau in regulating pathological amyloid aggregation. J Biol Chem 295:7470\u20137480. https:\/\/doi.org\/10.1074\/jbc.RA119.012284","journal-title":"J Biol Chem"},{"key":"6163_CR171","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.jmb.2018.04.020","volume":"430","author":"K Bhasne","year":"2018","unstructured":"Bhasne K, Sebastian S, Jain N, Mukhopadhyay S (2018) Synergistic amyloid switch triggered by early heterotypic oligomerization of intrinsically disordered \u03b1-synuclein and tau. J Mol Biol 430:2508\u20132520. https:\/\/doi.org\/10.1016\/j.jmb.2018.04.020","journal-title":"J Mol Biol"},{"key":"6163_CR172","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06846-9","volume":"12","author":"L Torres-Garcia","year":"2022","unstructured":"Torres-Garcia L, Domingues JMP, Brandi E et al (2022) Monitoring the interactions between alpha-synuclein and Tau in vitro and in vivo using bimolecular fluorescence complementation. Sci Rep 12. https:\/\/doi.org\/10.1038\/s41598-022-06846-9","journal-title":"Sci Rep"},{"key":"6163_CR173","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.1074\/jbc.M110.178905","volume":"286","author":"HY Qureshi","year":"2011","unstructured":"Qureshi HY, Paudel HK (2011) Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and \u03b1-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro. J Biol Chem 286:5055\u20135068. https:\/\/doi.org\/10.1074\/jbc.M110.178905","journal-title":"J Biol Chem"},{"key":"6163_CR174","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1111\/j.1742-4658.2011.08389.x","volume":"278","author":"F Kawakami","year":"2011","unstructured":"Kawakami F, Suzuki M, Shimada N et al (2011) Stimulatory effect of \u03b1 -synuclein on the tau-phosphorylation by GSK-3 \u03b2. FEBS J 278:4895\u20134904. https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08389.x","journal-title":"FEBS J"},{"key":"6163_CR175","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1096\/fj.08-120410","volume":"23","author":"T Duka","year":"2009","unstructured":"Duka T, Duka V, Joyce JN, Sidhu A (2009) \u03b1\u2010Synuclein contributes to GSK\u20103\u03b2\u2010catalyzed Tau phosphorylation in Parkinson\u2019s disease models. FASEB J 23:2820\u20132830. https:\/\/doi.org\/10.1096\/fj.08-120410","journal-title":"FASEB J"},{"key":"6163_CR176","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/j.1460-9568.2011.07660.x","volume":"33","author":"T Haggerty","year":"2011","unstructured":"Haggerty T, Credle J, Rodriguez O et al (2011) Hyperphosphorylated tau in an \u03b1-synuclein-overexpressing transgenic model of Parkinson\u2019s disease: tauopathy in transgenic mice and PD. Eur J Neurosci 33:1598\u20131610. https:\/\/doi.org\/10.1111\/j.1460-9568.2011.07660.x","journal-title":"Eur J Neurosci"},{"key":"6163_CR177","doi-asserted-by":"publisher","first-page":"7604","DOI":"10.1523\/JNEUROSCI.0297-11.2011","volume":"31","author":"EA Waxman","year":"2011","unstructured":"Waxman EA, Giasson BI (2011) Induction of intracellular tau aggregation is promoted by \u03b1-synuclein seeds and provides novel insights into the hyperphosphorylation of tau. J Neurosci 31:7604\u20137618. https:\/\/doi.org\/10.1523\/JNEUROSCI.0297-11.2011","journal-title":"J Neurosci"},{"key":"6163_CR178","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1082324","volume":"300","author":"BI Giasson","year":"2003","unstructured":"Giasson BI, Forman MS, Higuchi M et al (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300:636\u2013640. https:\/\/doi.org\/10.1126\/science.1082324","journal-title":"Science"},{"key":"6163_CR179","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/jnen\/nlab054","volume":"80","author":"Y Takaichi","year":"2021","unstructured":"Takaichi Y, Chambers JK, Ano Y et al (2021) Deposition of phosphorylated \u03b1-synuclein and activation of GSK-3\u03b2 and PP2A in the PS19 mouse model of tauopathy. J Neuropathol Exp Neurol 80:731\u2013740. https:\/\/doi.org\/10.1093\/jnen\/nlab054","journal-title":"J Neuropathol Exp Neurol"},{"key":"6163_CR180","doi-asserted-by":"publisher","first-page":"27323","DOI":"10.1021\/jacs.5c02811","volume":"147","author":"X Zhan","year":"2025","unstructured":"Zhan X, Li W, Hatterer E et al (2025) Strain-distinct \u03b1-synuclein and tau cross-seeding uncovered by correlative approach with optical photothermal infrared sub-micron imaging. J Am Chem Soc 147:27323\u201327340. https:\/\/doi.org\/10.1021\/jacs.5c02811","journal-title":"J Am Chem Soc"},{"key":"6163_CR181","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa090","volume":"2","author":"T Williams","year":"2020","unstructured":"Williams T, Sorrentino Z, Weinrich M et al (2020) Differential cross-seeding properties of tau and \u03b1-synuclein in mouse models of tauopathy and synucleinopathy. Brain Commun 2. https:\/\/doi.org\/10.1093\/braincomms\/fcaa090","journal-title":"Brain Commun"},{"key":"6163_CR182","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13024-025-00822-3","volume":"20","author":"N Franzmeier","year":"2025","unstructured":"Franzmeier N, Roemer-Cassiano SN, Bernhardt AM et al (2025) Alpha synuclein co-pathology is associated with accelerated amyloid-driven tau accumulation in Alzheimer\u2019s disease. Mol Neurodegener 20:31. https:\/\/doi.org\/10.1186\/s13024-025-00822-3","journal-title":"Mol Neurodegener"},{"key":"6163_CR183","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20192193","volume":"218","author":"F Bassil","year":"2020","unstructured":"Bassil F, Meymand ES, Brown HJ et al (2020) \u03b1-Synuclein modulates tau spreading in mouse brains. J Exp Med 218. https:\/\/doi.org\/10.1084\/jem.20192193","journal-title":"J Exp Med"},{"key":"6163_CR184","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fnmol.2019.00107","volume":"12","author":"E Vasili","year":"2019","unstructured":"Vasili E, Dominguez-Meijide A, Outeiro TF (2019) Spreading of \u03b1-synuclein and tau: a systematic comparison of the mechanisms involved. Front Mol Neurosci 12:107. https:\/\/doi.org\/10.3389\/fnmol.2019.00107","journal-title":"Front Mol Neurosci"},{"key":"6163_CR185","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026609","volume":"6","author":"N Badiola","year":"2011","unstructured":"Badiola N, De Oliveira RM, Herrera F et al (2011) Tau enhances \u03b1-synuclein aggregation and toxicity in cellular models of synucleinopathy. PLoS ONE 6. https:\/\/doi.org\/10.1371\/journal.pone.0026609","journal-title":"PLoS ONE"},{"key":"6163_CR186","doi-asserted-by":"publisher","DOI":"10.1002\/cplu.202300257","volume":"88","author":"A Ojeda","year":"2023","unstructured":"Ojeda A, Cofr\u00e9 V, Melo F et al (2023) \u03b1\u2010Synuclein drives tau\u2019s cytotoxic aggregates formation through hydrophobic interactions. ChemPlusChem 88. https:\/\/doi.org\/10.1002\/cplu.202300257","journal-title":"ChemPlusChem"},{"key":"6163_CR187","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1093\/brain\/awac171","volume":"145","author":"L Pan","year":"2022","unstructured":"Pan L, Li C, Meng L et al (2022) Tau accelerates \u03b1-synuclein aggregation and spreading in Parkinson\u2019s disease. Brain 145:3454\u20133471. https:\/\/doi.org\/10.1093\/brain\/awac171","journal-title":"Brain"},{"key":"6163_CR188","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","volume":"30","author":"LK Clinton","year":"2010","unstructured":"Clinton LK, Blurton-Jones M, Myczek K et al (2010) Synergistic interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 30:7281\u20137289. https:\/\/doi.org\/10.1523\/JNEUROSCI.0490-10.2010","journal-title":"J Neurosci"},{"key":"6163_CR189","doi-asserted-by":"publisher","first-page":"15832","DOI":"10.1007\/s12035-025-05248-y","volume":"62","author":"Y Yamamoto","year":"2025","unstructured":"Yamamoto Y, Kubota T, Noguchi D et al (2025) Co-expression of mutant tau and \u03b1-synuclein in neurons promotes tau phosphorylation, neuronal loss, and neuroinflammation in mouse brain. Mol Neurobiol 62:15832\u201315843. https:\/\/doi.org\/10.1007\/s12035-025-05248-y","journal-title":"Mol Neurobiol"},{"key":"6163_CR190","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1016\/j.neuron.2024.08.003","volume":"112","author":"J Xiang","year":"2024","unstructured":"Xiang J, Tang J, Kang F et al (2024) Gut-induced alpha-synuclein and tau propagation initiate Parkinson\u2019s and Alzheimer\u2019s disease co-pathology and behavior impairments. Neuron 112:3585-3601.e5. https:\/\/doi.org\/10.1016\/j.neuron.2024.08.003","journal-title":"Neuron"},{"key":"6163_CR191","doi-asserted-by":"publisher","first-page":"9754","DOI":"10.1523\/JNEUROSCI.0344-18.2018","volume":"38","author":"PJ Teravskis","year":"2018","unstructured":"Teravskis PJ, Covelo A, Miller EC et al (2018) A53T mutant alpha-synuclein induces tau-dependent postsynaptic impairment independently of neurodegenerative changes. J Neurosci 38:9754\u20139767. https:\/\/doi.org\/10.1523\/JNEUROSCI.0344-18.2018","journal-title":"J Neurosci"},{"key":"6163_CR192","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00401-019-02032-w","volume":"138","author":"B Singh","year":"2019","unstructured":"Singh B, Covelo A, Martell-Mart\u00ednez H et al (2019) Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of \u03b1-synucleinopathy. Acta Neuropathol (Berl) 138:551\u2013574. https:\/\/doi.org\/10.1007\/s00401-019-02032-w","journal-title":"Acta Neuropathol (Berl)"},{"issue":"1","key":"6163_CR193","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40035-022-00309-x","volume":"11","author":"SC Vermilyea","year":"2022","unstructured":"Vermilyea SC, Christensen A, Meints J et al (2022) Loss of tau expression attenuates neurodegeneration associated with \u03b1-synucleinopathy. Transl Neurodegener 11(1):34. https:\/\/doi.org\/10.1186\/s40035-022-00309-x","journal-title":"Transl Neurodegener"},{"key":"6163_CR194","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0245-9","volume":"13","author":"JE Gerson","year":"2018","unstructured":"Gerson JE, Farmer KM, Henson N et al (2018) Tau oligomers mediate \u03b1-synuclein toxicity and can be targeted by immunotherapy. Mol Neurodegener 13. https:\/\/doi.org\/10.1186\/s13024-018-0245-9","journal-title":"Mol Neurodegener"},{"key":"6163_CR195","doi-asserted-by":"publisher","first-page":"1204104","DOI":"10.3389\/fneur.2023.1204104","volume":"14","author":"K Raheel","year":"2023","unstructured":"Raheel K, Deegan G, Di Giulio I et al (2023) Sex differences in alpha-synucleinopathies: a systematic review. Front Neurol 14:1204104. https:\/\/doi.org\/10.3389\/fneur.2023.1204104","journal-title":"Front Neurol"},{"key":"6163_CR196","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00702-013-0972-6","volume":"120","author":"G Caranci","year":"2013","unstructured":"Caranci G, Piscopo P, Rivabene R et al (2013) Gender differences in Parkinson\u2019s disease: focus on plasma alpha-synuclein. J Neural Transm 120:1209\u20131215. https:\/\/doi.org\/10.1007\/s00702-013-0972-6","journal-title":"J Neural Transm"},{"key":"6163_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2025.578610","volume":"403","author":"R Bovenzi","year":"2025","unstructured":"Bovenzi R, Conti M, Simonetta C et al (2025) Sex-specific immune-biological profiles in Parkinson\u2019s disease. J Neuroimmunol 403. https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578610","journal-title":"J Neuroimmunol"},{"key":"6163_CR198","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1111\/ene.15801","volume":"30","author":"R Bovenzi","year":"2023","unstructured":"Bovenzi R, Sancesario GM, Conti M et al (2023) Sex hormones differentially contribute to Parkinson disease in males: a multimodal biomarker study. Eur J Neurol 30:1983\u20131990. https:\/\/doi.org\/10.1111\/ene.15801","journal-title":"Eur J Neurol"},{"key":"6163_CR199","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-026-01707-9","volume":"46","author":"M Zubelzu","year":"2026","unstructured":"Zubelzu M, Bidgood R, Murueta-Goyena A et al (2026) Sex-dependent dynamics of behavioural and neuropathological changes in an A53T alpha-synuclein mouse model of Parkinson\u2019s disease. Cell Mol Neurobiol 46. https:\/\/doi.org\/10.1007\/s10571-026-01707-9","journal-title":"Cell Mol Neurobiol"},{"key":"6163_CR200","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-025-00809-1","volume":"17","author":"LC Beauchamp","year":"2025","unstructured":"Beauchamp LC, Palumbo LA, Lanser TB et al (2025) Sex-dependent immune activation shapes disease progression in a model of Parkinson\u2019s disease. Biol Sex Differ 17. https:\/\/doi.org\/10.1186\/s13293-025-00809-1","journal-title":"Biol Sex Differ"},{"key":"6163_CR201","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41531-023-00606-w","volume":"9","author":"SA Ferreira","year":"2023","unstructured":"Ferreira SA, Li C, Kl\u00e6strup IH et al (2023) Sex-dimorphic neuroprotective effect of CD163 in an \u03b1-synuclein mouse model of Parkinson\u2019s disease. Npj Park Dis 9:164. https:\/\/doi.org\/10.1038\/s41531-023-00606-w","journal-title":"Npj Park Dis"},{"key":"6163_CR202","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1432342","author":"A Freuchet","year":"2024","unstructured":"Freuchet A, Pin\u00e7on A, Sette A, Lindestam Arlehamn CS (2024) Inflammation and heterogeneity in synucleinopathies. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1432342","journal-title":"Front Immunol"},{"key":"6163_CR203","doi-asserted-by":"publisher","DOI":"10.1002\/alz.093345","volume":"20","author":"MW Alexander","year":"2024","unstructured":"Alexander MW, Barnes LL, Schneider JA et al (2024) Synergism between Lewy body and Alzheimer\u2019s disease pathology differs by sex. Alzheimers Dement 20. https:\/\/doi.org\/10.1002\/alz.093345","journal-title":"Alzheimers Dement"},{"issue":"3","key":"6163_CR204","doi-asserted-by":"publisher","first-page":"e260461","DOI":"10.1001\/jamanetworkopen.2026.0461","volume":"9","author":"E Mak","year":"2026","unstructured":"Mak E, Fought AJ, Wiste HJ et al (2026) Sex-specific associations of \u03b1-synuclein pathology with tau accumulation. JAMA Netw Open 9(3):e260461. https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.0461","journal-title":"JAMA Netw Open"},{"key":"6163_CR205","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s42003-025-07680-1","volume":"8","author":"S Tullo","year":"2025","unstructured":"Tullo S, Park J, Gallino D et al (2025) Female mice exhibit resistance to disease progression despite early pathology in a transgenic mouse model inoculated with alpha-synuclein fibrils. Commun Biol 8:288. https:\/\/doi.org\/10.1038\/s42003-025-07680-1","journal-title":"Commun Biol"},{"key":"6163_CR206","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3389\/fphar.2020.00356","volume":"11","author":"M G\u00f3mez-Benito","year":"2020","unstructured":"G\u00f3mez-Benito M, Granado N, Garc\u00eda-Sanz P et al (2020) Modeling Parkinson\u2019s disease with the alpha-synuclein protein. Front Pharmacol 11:356. https:\/\/doi.org\/10.3389\/fphar.2020.00356","journal-title":"Front Pharmacol"},{"key":"6163_CR207","doi-asserted-by":"publisher","unstructured":"Matarazzo M, Borghammer P, Elsayed I et al (2026) Co\u2010 and multi\u2010pathologies in Parkinson\u2019s disease: an International Parkinson and Movement Disorder Society Scientific Issues Committee review. Mov Disord. https:\/\/doi.org\/10.1002\/mds.70324","DOI":"10.1002\/mds.70324"},{"key":"6163_CR208","doi-asserted-by":"publisher","unstructured":"Puzzo D, Privitera L, Fa\u2019 M, et al (2011) Endogenous amyloid-\u03b2 is necessary for hippocampal synaptic plasticity and memory. Ann Neurol 69:819\u2013830. https:\/\/doi.org\/10.1002\/ana.22313","DOI":"10.1002\/ana.22313"},{"key":"6163_CR209","doi-asserted-by":"crossref","unstructured":"Beach TG, Serrano GE, Driver-Dunckley ED, et al (2025) Parkinson disease neuropathological comorbidities: prevalences from younger-old to older-old, with comparison to non-demented, non-Parkinsonian subjects. 2025.01.13.25319971","DOI":"10.1101\/2025.01.13.25319971"},{"key":"6163_CR210","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-321111","author":"C Smith","year":"2019","unstructured":"Smith C, Malek N, Grosset K et al (2019) Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2019-321111","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6163_CR211","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/mds.26191","volume":"30","author":"M Petrou","year":"2015","unstructured":"Petrou M, Dwamena BA, Foerster BR et al (2015) Amyloid deposition in Parkinson\u2019s disease and cognitive impairment: a systematic review. Mov Disord 30:928\u2013935. https:\/\/doi.org\/10.1002\/mds.26191","journal-title":"Mov Disord"},{"key":"6163_CR212","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","volume":"52","author":"M Jo","year":"2020","unstructured":"Jo M, Lee S, Jeon Y-M et al (2020) The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies. Exp Mol Med 52:1652\u20131662. https:\/\/doi.org\/10.1038\/s12276-020-00513-7","journal-title":"Exp Mol Med"},{"key":"6163_CR213","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/WCO.0b013e3283168d1d","volume":"21","author":"IRA Mackenzie","year":"2008","unstructured":"Mackenzie IRA, Rademakers R (2008) The role of TDP-43 in amyotrophic lateral sclerosis and frontotemporal dementia. Curr Opin Neurol 21:693\u2013700. https:\/\/doi.org\/10.1097\/WCO.0b013e3283168d1d","journal-title":"Curr Opin Neurol"},{"key":"6163_CR214","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","volume":"114","author":"H Nakashima-Yasuda","year":"2007","unstructured":"Nakashima-Yasuda H, Uryu K, Robinson J et al (2007) Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol (Berl) 114:221\u2013229. https:\/\/doi.org\/10.1007\/s00401-007-0261-2","journal-title":"Acta Neuropathol (Berl)"},{"key":"6163_CR215","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104525","volume":"130","author":"JR Patterson","year":"2019","unstructured":"Patterson JR, Duffy MF, Kemp CJ et al (2019) Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal \u03b1-synuclein preformed fibrils. Neurobiol Dis 130. https:\/\/doi.org\/10.1016\/j.nbd.2019.104525","journal-title":"Neurobiol Dis"},{"key":"6163_CR216","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","volume":"82","author":"KL Paumier","year":"2015","unstructured":"Paumier KL, Luk KC, Manfredsson FP et al (2015) Intrastriatal injection of pre-formed mouse \u03b1-synuclein fibrils into rats triggers \u03b1-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiol Dis 82:185\u2013199. https:\/\/doi.org\/10.1016\/j.nbd.2015.06.003","journal-title":"Neurobiol Dis"},{"key":"6163_CR217","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3233\/JPD-240228","volume":"14","author":"AL Woerman","year":"2024","unstructured":"Woerman AL, Luk KC (2024) Are preformed fibrils a model of Parkinson\u2019s disease? J Park Dis 14:1095\u20131103. https:\/\/doi.org\/10.3233\/JPD-240228","journal-title":"J Park Dis"},{"key":"6163_CR218","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3233\/JPD-212847","volume":"11","author":"NK Polinski","year":"2021","unstructured":"Polinski NK (2021) A summary of phenotypes observed in the in vivo rodent alpha-synuclein preformed fibril model. J Park Dis 11:1555\u20131567. https:\/\/doi.org\/10.3233\/JPD-212847","journal-title":"J Park Dis"},{"key":"6163_CR219","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1084\/jem.20160833","volume":"213","author":"JL Guo","year":"2016","unstructured":"Guo JL, Narasimhan S, Changolkar L et al (2016) Unique pathological tau conformers from Alzheimer\u2019s brains transmit tau pathology in nontransgenic mice. J Exp Med 213:2635\u20132654. https:\/\/doi.org\/10.1084\/jem.20160833","journal-title":"J Exp Med"},{"key":"6163_CR220","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JPD-171248","volume":"8","author":"NK Polinski","year":"2018","unstructured":"Polinski NK, Volpicelli-Daley LA, Sortwell CE et al (2018) Best practices for generating and using alpha-synuclein pre-formed fibrils to model Parkinson\u2019s disease in rodents. J Park Dis 8:303\u2013322. https:\/\/doi.org\/10.3233\/JPD-171248","journal-title":"J Park Dis"},{"key":"6163_CR221","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3233\/JPD-212555","volume":"12","author":"M Negrini","year":"2022","unstructured":"Negrini M, Tomasello G, Davidsson M et al (2022) Sequential or simultaneous injection of preformed fibrils and AAV overexpression of alpha-synuclein are equipotent in producing relevant pathology and behavioral deficits. J Parkinsons Dis 12:1133\u20131153. https:\/\/doi.org\/10.3233\/JPD-212555","journal-title":"J Parkinsons Dis"},{"key":"6163_CR222","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1006\/nbdi.2001.0392","volume":"8","author":"Y Matsuoka","year":"2001","unstructured":"Matsuoka Y, Vila M, Lincoln S et al (2001) Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol Dis 8:535\u2013539. https:\/\/doi.org\/10.1006\/nbdi.2001.0392","journal-title":"Neurobiol Dis"},{"key":"6163_CR223","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3389\/fnins.2018.00621","volume":"12","author":"MF Duffy","year":"2018","unstructured":"Duffy MF, Collier TJ, Patterson JR et al (2018) Quality over quantity: advantages of using alpha-synuclein preformed fibril triggered synucleinopathy to model idiopathic Parkinson\u2019s disease. Front Neurosci 12:621. https:\/\/doi.org\/10.3389\/fnins.2018.00621","journal-title":"Front Neurosci"},{"key":"6163_CR224","doi-asserted-by":"publisher","DOI":"10.1172\/JCI168553","volume":"133","author":"N Samudra","year":"2023","unstructured":"Samudra N, Lane-Donovan C, VandeVrede L, Boxer AL (2023) Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenues. J Clin Invest 133. https:\/\/doi.org\/10.1172\/JCI168553","journal-title":"J Clin Invest"},{"key":"6163_CR225","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1149761","volume":"17","author":"N Sahara","year":"2023","unstructured":"Sahara N, Yanai R (2023) Limitations of human tau-expressing mouse models and novel approaches of mouse modeling for tauopathy. Front Neurosci 17. https:\/\/doi.org\/10.3389\/fnins.2023.1149761","journal-title":"Front Neurosci"},{"key":"6163_CR226","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0277532","volume":"17","author":"WK Raja","year":"2022","unstructured":"Raja WK, Neves E, Burke C et al (2022) Patient-derived three-dimensional cortical neurospheres to model Parkinson\u2019s disease. PLoS ONE 17. https:\/\/doi.org\/10.1371\/journal.pone.0277532","journal-title":"PLoS ONE"},{"key":"6163_CR227","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1093\/brain\/awae365","volume":"148","author":"E Frattini","year":"2025","unstructured":"Frattini E, Faustini G, Lopez G et al (2025) Lewy pathology formation in patient-derived GBA1 Parkinson\u2019s disease midbrain organoids. Brain 148:1242\u20131257. https:\/\/doi.org\/10.1093\/brain\/awae365","journal-title":"Brain"},{"key":"6163_CR228","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/17460441.2020.1703671","volume":"15","author":"N Marotta","year":"2020","unstructured":"Marotta N, Kim S, Krainc D (2020) Organoid and pluripotent stem cells in Parkinson\u2019s disease modeling: an expert view on their value to drug discovery. Expert Opin Drug Discov 15:427\u2013441. https:\/\/doi.org\/10.1080\/17460441.2020.1703671","journal-title":"Expert Opin Drug Discov"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06163-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06163-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06163-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:04:32Z","timestamp":1788872672000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06163-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":228,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6163"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06163-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"882"}}